Literature DB >> 6578111

Characteristics of platelet aggregation induced by the monoclonal antibody ALB6 (acute lymphoblastic leukemia antigen p 24). Inhibition of aggregation by ALB6Fab.

C Boucheix, C Soria, M Mirshahi, J Soria, J Y Perrot, N Fournier, M Billard, C Rosenfeld.   

Abstract

The leukemia-associated cell surface antigen p 24 is found on normal platelets as well as on Bernard Soulier syndrome and thrombasthenia type I platelets. ALB6 IgG (a monoclonal antibody against p 24) induces the aggregation of platelets from normal donors but not from thrombasthenia. In contrast, ALB6 Fab inhibits platelet aggregation induced by collagen, ADP, thrombin, ionophore A 23187 and ALB6 IgG. The results suggest that ALB6 interferes with a mechanism common to all aggregation pathways; the possible mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6578111     DOI: 10.1016/0014-5793(83)81027-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor.

Authors:  T E O'Toole; J C Loftus; X P Du; A A Glass; Z M Ruggeri; S J Shattil; E F Plow; M H Ginsberg
Journal:  Cell Regul       Date:  1990-11

2.  The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers.

Authors:  E Fernvik; J Lundahl; G Halldén
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

3.  Assignment of the human CD9 gene to chromosome 12 (region P13) by use of human specific DNA probes.

Authors:  P Benoit; M S Gross; P Frachet; J Frézal; G Uzan; C Boucheix; V C Nguyen
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

4.  Analysis of the tetraspanin CD9-integrin alphaIIbbeta3 (GPIIb-IIIa) complex in platelet membranes and transfected cells.

Authors:  F E Indig; F Diaz-Gonzalez; M H Ginsberg
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

5.  Stimulus-response coupling in human platelets activated by monoclonal antibodies to the CD9 antigen, a 24 kDa surface-membrane glycoprotein.

Authors:  R C Carroll; R E Worthington; C Boucheix
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

6.  Extracellular matrix receptor and platelet antigens on osteoclasts and foreign body giant cells.

Authors:  J M Quinn; N A Athanasou; J O McGee
Journal:  Histochemistry       Date:  1991

7.  Differential effect of the inhibition of Grb2-SH3 interactions in platelet activation induced by thrombin and by Fc receptor engagement.

Authors:  Abdelhafid Saci; Wang-Qing Liu; Michel Vidal; Christiane Garbay; Francine Rendu; Christilla Bachelot-Loza
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

8.  Preparation of fibroblast-free cytotrophoblast cultures utilizing differential expression of the CD9 antigen.

Authors:  D W Morrish; A R Shaw; J Seehafer; D Bhardwaj; M T Paras
Journal:  In Vitro Cell Dev Biol       Date:  1991-04

Review 9.  Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.

Authors:  S Detchokul; E D Williams; M W Parker; A G Frauman
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

10.  Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain.

Authors:  Cunji Gao; Brian Boylan; Dan Bougie; Joan C Gill; Jessica Birenbaum; Debra K Newman; Richard H Aster; Peter J Newman
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.